(R)-N-Boc-3-amino-4-(4-fluorophenyl)butyric acid is a chiral, non-natural amino acid derivative. Its structure features a (R)-configured stereocenter, a tert-butoxycarbonyl (Boc) protected amine group, a carboxylic acid terminus, and a 4-fluorophenyl side chain. This combination of functional groups makes it a versatile and valuable building block in organic synthesis. This compound is primarily employed as a key chiral intermediate in the pharmaceutical industry for the synthesis of active pharmaceutical ingredients (APIs). Its most notable application is in the production of Omarigliptin (MK-3102), a once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor developed for the treatment of type 2 diabetes. The (R)-configuration and the fluorinated aromatic moiety are critical for the biological activity and metabolic stability of the final drug molecule. As a Boc-protected β-amino acid with an aromatic fluorophenyl group, it serves as a crucial precursor for constructing peptidomimetics and other bioactive molecules. Its high enantiomeric purity is essential for ensuring the efficacy and safety profile of the resulting pharmaceuticals.